The Role of TDP-43 in Alzheimer's Disease

被引：66
作者：
Chang, Xiao-Long [1 ]
Tan, Meng-Shan [2 ]
Tan, Lan [1 ,2 ]
Yu, Jin-Tai [2 ,3 ]
机构：
[1] Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Med, Qingdao Municipal Hosp, Dept Neurol, Qingdao 266071, Peoples R China
[3] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA
来源：
MOLECULAR NEUROBIOLOGY | 2016年 / 53卷 / 05期
基金：
中国国家自然科学基金;
关键词：
TDP-43; A beta; Tau; Alzheimer's disease; Pathogenesis; Therapy; AMYOTROPHIC-LATERAL-SCLEROSIS; TAR-DNA-BINDING; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; MOUSE MODEL; PROTEIN; 43; MITOCHONDRIAL DYSFUNCTION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE;
D O I：
10.1007/s12035-015-9264-5
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The transactive response DNA binding protein (TDP-43) has long been characterized as a main hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U, also known as FTLD-TDP). Several studies have indicated TDP-43 deposits in Alzheimer's disease (AD) brains and have robust connection with AD clinical phenotype. FTLD-U, which was symptomatically connected with AD, may be predictable for the comprehension of the role TDP-43 in AD. TDP-43 may contribute to AD through both beta-amyloid (A beta)-dependent and A beta-independent pathways. In this article, we summarize the latest studies concerning the role of TDP-43 in AD and explore TDP-43 modulation as a potential therapeutic strategy for AD. However, to date, little of pieces of the research on TDP-43 have been performed to investigate the role in AD; more investigations need to be confirmed in the future.
引用
收藏
页码：3349 / 3359
页数：11
相关论文
共 91 条
  • [41] Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies
    Igaz, Lionel M.
    Kwong, Linda K.
    Chen-Plotkin, Alice
    Winton, Matthew J.
    Unger, Travis L.
    Xu, Yan
    Neumann, Manuela
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (13) : 8516 - 8524
  • [42] PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43
    Joardar, Archi
    Menzl, Judith
    Podolsky, Taylor C.
    Manzo, Ernesto
    Estes, Patricia S.
    Ashford, Sarah
    Zarnescu, Daniela C.
    [J]. HUMAN MOLECULAR GENETICS, 2015, 24 (06) : 1741 - 1754
  • [43] Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype
    Josephs, K. A.
    Whitwell, J. L.
    Knopman, D. S.
    Hu, W. T.
    Stroh, D. A.
    Baker, M.
    Rademakers, R.
    Boeve, B. F.
    Parisi, J. E.
    Smith, G. E.
    Ivnik, R. J.
    Petersen, R. C.
    Jack, C. R., Jr.
    Dickson, D. W.
    [J]. NEUROLOGY, 2008, 70 (19) : 1850 - 1857
  • [44] TDP-43 is a key player in the clinical features associated with Alzheimer's disease
    Josephs, Keith A.
    Whitwell, Jennifer L.
    Weigand, Stephen D.
    Murray, Melissa E.
    Tosakulwong, Nirubol
    Liesinger, Amanda M.
    Petrucelli, Leonard
    Senjem, Matthew L.
    Knopman, David S.
    Boeve, Bradley F.
    Ivnik, Robert J.
    Smith, Glenn E.
    Jack, Clifford R., Jr.
    Parisi, Joseph E.
    Petersen, Ronald C.
    Dickson, Dennis W.
    [J]. ACTA NEUROPATHOLOGICA, 2014, 127 (06) : 811 - 824
  • [45] Staging TDP-43 pathology in Alzheimer's disease
    Josephs, Keith A.
    Murray, Melissa E.
    Whitwell, Jennifer L.
    Parisi, Joseph E.
    Petrucelli, Leonard
    Jack, Clifford R.
    Petersen, Ronald C.
    Dickson, Dennis W.
    [J]. ACTA NEUROPATHOLOGICA, 2014, 127 (03) : 441 - 450
  • [46] TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism
    Jung, Youngsin
    Dickson, Dennis W.
    Murray, Melissa E.
    Whitwell, Jennifer L.
    Knopman, David S.
    Boeve, Bradley F.
    Jack, Clifford R., Jr.
    Parisi, Joseph E.
    Petersen, Ronald C.
    Josephs, Keith A.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 (07) : 1344 - 1348
  • [47] Progranulin and TDP-43: Mechanistic Links and Future Directions
    Kumar-Singh, Samir
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (03) : 561 - 573
  • [48] The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids
    Kuo, Pan-Hsien
    Chiang, Chien-Hao
    Wang, Yi-Ting
    Doudeva, Lyudmila G.
    Yuan, Hanna S.
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (07) : 4712 - 4722
  • [49] NEUROINFLAMMATION IN ALZHEIMER'S DISEASE; A SOURCE OF HETEROGENEITY AND TARGET FOR PERSONALIZED THERAPY
    Latta, C. H.
    Brothers, H. M.
    Wilcock, D. M.
    [J]. NEUROSCIENCE, 2015, 302 : 103 - 111
  • [50] Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes
    Lauranzano, Eliana
    Pozzi, Silvia
    Pasetto, Laura
    Stucchi, Riccardo
    Massignan, Tania
    Paolella, Katia
    Mombrini, Melissa
    Nardo, Giovanni
    Lunetta, Christian
    Corbo, Massimo
    Mora, Gabriele
    Bendotti, Caterina
    Bonetto, Valentina
    [J]. BRAIN, 2015, 138 : 974 - 991
12345678910